文献速递新发突发、热带与寄生虫病

功能性抗疟免疫对青蒿素衍生物疗效研究中寄生虫清除指标的贡献

Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
PubMed 文献 · J Infect Dis · 2019-01-01

该研究在东南亚11个中心评估青蒿素联合疗法疗效,检测恶性疟原虫裂殖子抗原特异性IgG亚类、C1q固定及调理吞噬抗体,并分析其与寄生虫清除半衰期的关系。结果显示IgG3、C1q固定和调理吞噬抗体阳性与更快的清除半衰期及更低的高清除半衰期和3天疟原虫血症风险相关,且抗体流行率随传播强度变化。

要点

  • IgG3是主要IgG亚类,其流行率随传播强度变化,低传播区最低。
  • IgG3、C1q固定和调理吞噬抗体阳性与更快寄生虫清除半衰期相关。
  • 这些功能性抗体可能作为增强感染红细胞清除能力的敏感替代标志物。

核心结论

  • IgG3、补体固定抗体和裂殖子吞噬的流行率随传播强度变化,与更快的寄生虫清除相关,并可能作为增强感染红细胞清除能力的敏感替代标志物。

研究设计与样本

  • 多国试验评估青蒿琥酯疗效,覆盖东南亚11个研究点,检测IgG亚类、C1q固定及调理吞噬抗体,回归分析抗体血清阳性对寄生虫清除半衰期等指标的影响。

主要发现

  • IgG3是主要IgG亚类,IgG1血清流行率范围5%-35%,IgG3为27%-41%,各研究点间有差异,低传播强度且平均寄生虫清除半衰期最慢的研究点最低。
  • IgG3、C1q固定和调理吞噬血清阳性与更快的寄生虫清除半衰期相关,平均缩短范围0.47-1.16小时,P值范围.001-.03。
  • 上述抗体阳性与寄生虫清除半衰期≥5小时及治疗后3天疟原虫血症的比值比降低相关。

临床怎么用

  • 功能性抗体标志物可能有助于评估青蒿素耐药性,但需进一步验证其临床效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibodies to the blood stages of malaria parasites enhance parasite clearance and antimalarial efficacy. The antibody subclass and functions that contribute to parasite clearance during antimalarial treatment and their relationship to malaria transmission intensity have not been characterized. METHODS: Levels of immunoglobulin G (IgG) subclasses and C1q fixation in response to Plasmodium falciparum merozoite antigens (erythrocyte-binding antigen [EBA] 175RIII-V, merozoite surface protein 2 [MSP-2], and MSP-142) and opsonic phagocytosis of merozoites were measured in a multinational trial assessing the efficacy of artesunate therapy across 11 Southeast Asian sites. Regression analyses assessed the effects of antibody seropositivity on the parasite clearance half-life (PC½), having a PC½ of ≥5 hours, and having parasitemia 3 days after treatment. RESULTS: IgG3, followed by IgG1, was the predominant IgG subclass detected (seroprevalence range, 5%-35% for IgG1 and 27%-41% for IgG3), varied across study sites, and was lowest in study sites with the lowest transmission intensity and slowest mean PC½. IgG3, C1q fixation, and opsonic-phagocytosis seropositivity were associated with a faster PC½ (range of the mean reduction in PC½, 0.47-1.16 hours; P range, .001-.03) and a reduced odds of having a PC½ of ≥5 hours and having parasitemia 3 days after treatment. CONCLUSIONS: The prevalence of IgG3, complement-fixing antibodies, and merozoite phagocytosis vary according to transmission intensity, are associated with faster parasite clearance, and may be sensitive surrogates of an augmented clearance capacity of infected erythrocytes. Determining the functional immune mechanisms associated with parasite clearance will improve characterization of artemisinin resistance.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. O'Flaherty K, Ataíde R, Zaloumis SG, et al. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives. J Infect Dis. 2019. PMID: 31075171. doi:10.1093/infdis/jiz247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。